Efficacy and safety of parasternal blocks in children undergoing pediatric heart surgery: a retrospective cohort study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00035234

Enrollment

110

Registered

2024-10-08

Start date

2023-01-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Q24

Interventions

Group 1: Children undergoing a Fontan surgical procedure or an ASD closure received a bilateral ultrasound guided parasternal block with 1ml/kg ropivacaine 0,2% at the end of anaesthesia induction Gro

Eligibility

Sex/Gender

All

Age

No minimum to 18 Years

Inclusion criteria

Inclusion criteria: Children undergoing Fontan surgery or ASD closure

Exclusion criteria

Exclusion criteria: Other pediatric surgical procedures

Design outcomes

Primary

Measure	Time frame
Worst pain intensity within the first 24 hours after surgery	—

Secondary

Measure	Time frame
-Postoperative pain intensity at rest 4, 8, 12, 24h postoperatively -Mean opioid consumption within the first 24 hours after surgery -Incidence of postoperative nausea and vomiting within the first 24 hours after surgery -Mean non-opioid consumption within the first 24 hours after surgery (paracetamol, metamizol) -first blood gas analysis after extubation on the pediatric intensive care unit (PICU) - Incidence of noninvasive ventilation, reintubation on the PICU length of PICU duration - block-related adverse events	—

Measure

Time frame

-Postoperative pain intensity at rest 4, 8, 12, 24h postoperatively -Mean opioid consumption within the first 24 hours after surgery -Incidence of postoperative nausea and vomiting within the first 24 hours after surgery -Mean non-opioid consumption within the first 24 hours after surgery (paracetamol, metamizol) -first blood gas analysis after extubation on the pediatric intensive care unit (PICU) - Incidence of noninvasive ventilation, reintubation on the PICU length of PICU duration - block-related adverse events

—

Countries

Germany

Contacts

Public ContactAlexander Schnabel

Universitätsklinik Münster

alexander.schnabel@ukmuenster.de00492518347255

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026